Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Sevasemten

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edgewise Therapeutics Reports Q2 2025 Financials and Business
    Edgewise Therapeutics Reports Q2 2025 Financials and Business

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-second-quarter-2025-financial-results-and-recent-business-highlights-302523640.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Edgewise Gets EMA Orphan Designation for Muscular Dystrophies Drug
    Edgewise Gets EMA Orphan Designation for Muscular Dystrophies Drug

    23 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240423844146/en

    BUSINESSWIRE
    23 Apr 2024
    Share Share
    Edgewise Positive 2-Year Becker Sevasemten Topline Data
    Edgewise Positive 2-Year Becker Sevasemten Topline Data

    15 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240415221564/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share